• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

尼罗替尼用于肝移植后治疗与伊马替尼相关的急性肝衰竭。

Nilotinib post-liver transplantation for acute hepatic failure related to imatinib.

作者信息

Perini Guilherme F, Santos Fabio P S, Funke Vaneuza, Ruiz Jefferson, Neto Ben-Hur Ferraz, Hamerschlak Nelson

机构信息

Hospital Israelita Albert Einstein, Sao Paulo (SP), Brazil.

出版信息

Leuk Res. 2009 Dec;33(12):e234-5. doi: 10.1016/j.leukres.2009.06.012. Epub 2009 Jul 25.

DOI:10.1016/j.leukres.2009.06.012
PMID:19632720
Abstract

This is the case report of a 47-year-old woman referred to our institution due to acute liver failure related to imatinib, who was submitted to a successful liver transplantation. Nilotinib was safely used post-transplant.

摘要

这是一例47岁女性的病例报告，该患者因与伊马替尼相关的急性肝衰竭转诊至我院，并成功接受了肝移植。移植后安全使用了尼罗替尼。

相似文献

1
Nilotinib post-liver transplantation for acute hepatic failure related to imatinib.尼罗替尼用于肝移植后治疗与伊马替尼相关的急性肝衰竭。
Leuk Res. 2009 Dec;33(12):e234-5. doi: 10.1016/j.leukres.2009.06.012. Epub 2009 Jul 25.
2
[Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia].[伊马替尼致慢性髓性白血病患者暴发性肝炎]
Med Clin (Barc). 2011 Sep 17;137(7):329-30. doi: 10.1016/j.medcli.2010.09.011. Epub 2010 Nov 11.
3
Imatinib-induced fatal acute liver failure.伊马替尼诱发的致命性急性肝衰竭。
World J Gastroenterol. 2007 Dec 28;13(48):6608-111. doi: 10.3748/wjg.v13.i48.6608.
4
Nilotinib in a patient with postnecrotic liver cirrhosis related to imatinib.尼洛替尼治疗一名与伊马替尼相关的坏死性肝硬化患者。
J Clin Oncol. 2011 Jan 20;29(3):e50-2. doi: 10.1200/JCO.2010.30.5359. Epub 2010 Oct 18.
5
[Survival following liver transplant due to imatinib-induced acute liver failure: a case study].[伊马替尼诱导的急性肝衰竭肝移植后的生存情况：病例研究]
Farm Hosp. 2012 Jan-Feb;36(1):50-1. doi: 10.1016/j.farma.2010.12.004. Epub 2011 Apr 22.
6
Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.甲磺酸伊马替尼所致肝损伤在一名未经治疗的慢性期慢性粒细胞白血病患者中的成功管理。
Leuk Lymphoma. 2006 Jul;47(7):1427-30. doi: 10.1080/10428190600593877.
7
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.尼罗替尼（原AMN107）是一种高度选择性的BCR-ABL酪氨酸激酶抑制剂，对伊马替尼耐药和不耐受的慢性期费城染色体阳性慢性髓性白血病患者有效。
Blood. 2007 Nov 15;110(10):3540-6. doi: 10.1182/blood-2007-03-080689. Epub 2007 Aug 22.
8
Imatinib mesylate as a cause of acute liver failure.甲磺酸伊马替尼导致急性肝衰竭。
Am J Hematol. 2006 Mar;81(3):189-92. doi: 10.1002/ajh.20486.
9
[Imatinib mesylate-induced acute cytolytic hepatitis].甲磺酸伊马替尼诱导的急性细胞溶解性肝炎
Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):918-9. doi: 10.1016/s0399-8320(04)95160-3.
10
Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.

引用本文的文献

1
A Case of Severe, Nilotinib-Induced Liver Injury.一例严重的、尼洛替尼诱发的肝损伤病例。
ACG Case Rep J. 2019 Feb 25;6(2):e00003. doi: 10.14309/crj.0000000000000003. eCollection 2019 Feb.
2
Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury.基于评分的新型决策方法在伊马替尼急性毒性诱导肝损伤后的慢性髓性白血病患者中的应用
Cureus. 2019 Apr 9;11(4):e4411. doi: 10.7759/cureus.4411.
3
Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.
慢性粒细胞白血病、磺胺过敏和类风湿关节炎患者急性伊马替尼诱导性肝炎病例报告
Cureus. 2018 Aug 13;10(8):e3136. doi: 10.7759/cureus.3136.
4
Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report.伊马替尼致慢性髓性白血病暴发性肝衰竭：肝移植及第二代酪氨酸激酶抑制剂的作用：一例报告
J Med Case Rep. 2018 Mar 10;12(1):63. doi: 10.1186/s13256-018-1588-0.
5
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.欧洲白血病网关于慢性髓性白血病治疗管理及不良事件避免的建议
Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28.
6
Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.达沙替尼治疗伊马替尼诱导肝毒性后的慢性髓性白血病。
Int J Hematol. 2014 Jan;99(1):91-4. doi: 10.1007/s12185-013-1474-x. Epub 2013 Nov 22.
7
Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.两名慢性期慢性髓性白血病患者在接受羟基脲治疗后紧接着使用尼罗替尼治疗后发生肿瘤溶解综合征。
Int J Hematol. 2013 Aug;98(2):243-6. doi: 10.1007/s12185-013-1356-2. Epub 2013 May 7.